Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Gabapentin market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Gabapentin market. Detailed analysis of key players, along with key growth strategies adopted by Gabapentin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Arbor Pharma
Amneal
Sun Pharmaceutical
Apotex
Aurobindo Pharma
Mylan
Alkem
Jiangsu Hengrui
Jiangsu Enhua
Marksans Pharma
Novartis
Assertio Therapeutics
Intas
TEVA
Sailike
Glenmark
By Type:
Capsule
Tablet
By End-User:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gabapentin Market
-
1.3 Market Segment by Type
-
1.3.1 China Gabapentin Market Size and Growth Rate of Capsule from 2016 to 2027
-
1.3.2 China Gabapentin Market Size and Growth Rate of Tablet from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Gabapentin Market Size and Growth Rate of Epilepsy from 2016 to 2027
-
1.4.2 China Gabapentin Market Size and Growth Rate of Neuropathic Pain from 2016 to 2027
-
1.4.3 China Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2016 to 2027
-
1.4.4 China Gabapentin Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gabapentin Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gabapentin by Major Types
-
3.4.1 Market Size and Growth Rate of Capsule
-
3.4.2 Market Size and Growth Rate of Tablet
4 Segmentation of Gabapentin Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gabapentin by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gabapentin in Epilepsy
-
4.4.2 Market Size and Growth Rate of Gabapentin in Neuropathic Pain
-
4.4.3 Market Size and Growth Rate of Gabapentin in Restless Legs Syndrome
-
4.4.4 Market Size and Growth Rate of Gabapentin in Others
5 Market Analysis by Regions
-
5.1 China Gabapentin Production Analysis by Regions
-
5.2 China Gabapentin Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Gabapentin Landscape Analysis
-
6.1 North China Gabapentin Landscape Analysis by Major Types
-
6.2 North China Gabapentin Landscape Analysis by Major End-Users
7 Central China Gabapentin Landscape Analysis
-
7.1 Central China Gabapentin Landscape Analysis by Major Types
-
7.2 Central China Gabapentin Landscape Analysis by Major End-Users
8 South China Gabapentin Landscape Analysis
-
8.1 South China Gabapentin Landscape Analysis by Major Types
-
8.2 South China Gabapentin Landscape Analysis by Major End-Users
9 East China Gabapentin Landscape Analysis
-
9.1 East China Gabapentin Landscape Analysis by Major Types
-
9.2 East China Gabapentin Landscape Analysis by Major End-Users
10 Northeast China Gabapentin Landscape Analysis
-
10.1 Northeast China Gabapentin Landscape Analysis by Major Types
-
10.2 Northeast China Gabapentin Landscape Analysis by Major End-Users
11 Southwest China Gabapentin Landscape Analysis
-
11.1 Southwest China Gabapentin Landscape Analysis by Major Types
-
11.2 Southwest China Gabapentin Landscape Analysis by Major End-Users
12 Northwest China Gabapentin Landscape Analysis
-
12.1 Northwest China Gabapentin Landscape Analysis by Major Types
-
12.2 Northwest China Gabapentin Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Arbor Pharma
-
13.1.1 Arbor Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Amneal
-
13.2.1 Amneal Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sun Pharmaceutical
-
13.3.1 Sun Pharmaceutical Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Apotex
-
13.4.1 Apotex Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Aurobindo Pharma
-
13.5.1 Aurobindo Pharma Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Mylan
-
13.6.1 Mylan Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Alkem
-
13.7.1 Alkem Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Jiangsu Hengrui
-
13.8.1 Jiangsu Hengrui Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Jiangsu Enhua
-
13.9.1 Jiangsu Enhua Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Marksans Pharma
-
13.10.1 Marksans Pharma Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Novartis
-
13.11.1 Novartis Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Assertio Therapeutics
-
13.12.1 Assertio Therapeutics Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Intas
-
13.13.1 Intas Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
-
13.14 TEVA
-
13.14.1 TEVA Company Profile and Recent Development
-
13.14.2 Market Performance
-
13.14.3 Product and Service Introduction
-
13.15 Sailike
-
13.15.1 Sailike Company Profile and Recent Development
-
13.15.2 Market Performance
-
13.15.3 Product and Service Introduction
-
13.16 Glenmark
-
13.16.1 Glenmark Company Profile and Recent Development
-
13.16.2 Market Performance
-
13.16.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Gabapentin Market Size and Growth Rate of Capsule from 2016 to 2027
-
Figure China Gabapentin Market Size and Growth Rate of Tablet from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Gabapentin Market Size and Growth Rate of Epilepsy from 2016 to 2027
-
Figure China Gabapentin Market Size and Growth Rate of Neuropathic Pain from 2016 to 2027
-
Figure China Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2016 to 2027
-
Figure China Gabapentin Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Gabapentin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gabapentin Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gabapentin
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gabapentin by Different Types from 2016 to 2027
-
Table Consumption Share of Gabapentin by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Capsule
-
Figure Market Size and Growth Rate of Tablet
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gabapentin by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gabapentin by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Epilepsy
-
Figure Market Size and Growth Rate of Neuropathic Pain
-
Figure Market Size and Growth Rate of Restless Legs Syndrome
-
Figure Market Size and Growth Rate of Others
-
Table China Gabapentin Production by Regions
-
Table China Gabapentin Production Share by Regions
-
Figure China Gabapentin Production Share by Regions in 2016
-
Figure China Gabapentin Production Share by Regions in 2021
-
Figure China Gabapentin Production Share by Regions in 2027
-
Table China Gabapentin Consumption by Regions
-
Table China Gabapentin Consumption Share by Regions
-
Figure China Gabapentin Consumption Share by Regions in 2016
-
Figure China Gabapentin Consumption Share by Regions in 2021
-
Figure China Gabapentin Consumption Share by Regions in 2027
-
Table North China Gabapentin Consumption by Types from 2016 to 2027
-
Table North China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure North China Gabapentin Consumption Share by Types in 2016
-
Figure North China Gabapentin Consumption Share by Types in 2021
-
Figure North China Gabapentin Consumption Share by Types in 2027
-
Table North China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table North China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure North China Gabapentin Consumption Share by End-Users in 2016
-
Figure North China Gabapentin Consumption Share by End-Users in 2021
-
Figure North China Gabapentin Consumption Share by End-Users in 2027
-
Table Central China Gabapentin Consumption by Types from 2016 to 2027
-
Table Central China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure Central China Gabapentin Consumption Share by Types in 2016
-
Figure Central China Gabapentin Consumption Share by Types in 2021
-
Figure Central China Gabapentin Consumption Share by Types in 2027
-
Table Central China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table Central China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Gabapentin Consumption Share by End-Users in 2016
-
Figure Central China Gabapentin Consumption Share by End-Users in 2021
-
Figure Central China Gabapentin Consumption Share by End-Users in 2027
-
Table South China Gabapentin Consumption by Types from 2016 to 2027
-
Table South China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure South China Gabapentin Consumption Share by Types in 2016
-
Figure South China Gabapentin Consumption Share by Types in 2021
-
Figure South China Gabapentin Consumption Share by Types in 2027
-
Table South China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table South China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure South China Gabapentin Consumption Share by End-Users in 2016
-
Figure South China Gabapentin Consumption Share by End-Users in 2021
-
Figure South China Gabapentin Consumption Share by End-Users in 2027
-
Table East China Gabapentin Consumption by Types from 2016 to 2027
-
Table East China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure East China Gabapentin Consumption Share by Types in 2016
-
Figure East China Gabapentin Consumption Share by Types in 2021
-
Figure East China Gabapentin Consumption Share by Types in 2027
-
Table East China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table East China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure East China Gabapentin Consumption Share by End-Users in 2016
-
Figure East China Gabapentin Consumption Share by End-Users in 2021
-
Figure East China Gabapentin Consumption Share by End-Users in 2027
-
Table Northeast China Gabapentin Consumption by Types from 2016 to 2027
-
Table Northeast China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Gabapentin Consumption Share by Types in 2016
-
Figure Northeast China Gabapentin Consumption Share by Types in 2021
-
Figure Northeast China Gabapentin Consumption Share by Types in 2027
-
Table Northeast China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table Northeast China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Gabapentin Consumption Share by End-Users in 2016
-
Figure Northeast China Gabapentin Consumption Share by End-Users in 2021
-
Figure Northeast China Gabapentin Consumption Share by End-Users in 2027
-
Table Southwest China Gabapentin Consumption by Types from 2016 to 2027
-
Table Southwest China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Gabapentin Consumption Share by Types in 2016
-
Figure Southwest China Gabapentin Consumption Share by Types in 2021
-
Figure Southwest China Gabapentin Consumption Share by Types in 2027
-
Table Southwest China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table Southwest China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Gabapentin Consumption Share by End-Users in 2016
-
Figure Southwest China Gabapentin Consumption Share by End-Users in 2021
-
Figure Southwest China Gabapentin Consumption Share by End-Users in 2027
-
Table Northwest China Gabapentin Consumption by Types from 2016 to 2027
-
Table Northwest China Gabapentin Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Gabapentin Consumption Share by Types in 2016
-
Figure Northwest China Gabapentin Consumption Share by Types in 2021
-
Figure Northwest China Gabapentin Consumption Share by Types in 2027
-
Table Northwest China Gabapentin Consumption by End-Users from 2016 to 2027
-
Table Northwest China Gabapentin Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Gabapentin Consumption Share by End-Users in 2016
-
Figure Northwest China Gabapentin Consumption Share by End-Users in 2021
-
Figure Northwest China Gabapentin Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Arbor Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbor Pharma
-
Figure Sales and Growth Rate Analysis of Arbor Pharma
-
Figure Revenue and Market Share Analysis of Arbor Pharma
-
Table Product and Service Introduction of Arbor Pharma
-
Table Company Profile and Development Status of Amneal
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amneal
-
Figure Sales and Growth Rate Analysis of Amneal
-
Figure Revenue and Market Share Analysis of Amneal
-
Table Product and Service Introduction of Amneal
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Apotex
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex
-
Figure Sales and Growth Rate Analysis of Apotex
-
Figure Revenue and Market Share Analysis of Apotex
-
Table Product and Service Introduction of Apotex
-
Table Company Profile and Development Status of Aurobindo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma
-
Figure Sales and Growth Rate Analysis of Aurobindo Pharma
-
Figure Revenue and Market Share Analysis of Aurobindo Pharma
-
Table Product and Service Introduction of Aurobindo Pharma
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Alkem
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkem
-
Figure Sales and Growth Rate Analysis of Alkem
-
Figure Revenue and Market Share Analysis of Alkem
-
Table Product and Service Introduction of Alkem
-
Table Company Profile and Development Status of Jiangsu Hengrui
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Hengrui
-
Figure Sales and Growth Rate Analysis of Jiangsu Hengrui
-
Figure Revenue and Market Share Analysis of Jiangsu Hengrui
-
Table Product and Service Introduction of Jiangsu Hengrui
-
Table Company Profile and Development Status of Jiangsu Enhua
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Enhua
-
Figure Sales and Growth Rate Analysis of Jiangsu Enhua
-
Figure Revenue and Market Share Analysis of Jiangsu Enhua
-
Table Product and Service Introduction of Jiangsu Enhua
-
Table Company Profile and Development Status of Marksans Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marksans Pharma
-
Figure Sales and Growth Rate Analysis of Marksans Pharma
-
Figure Revenue and Market Share Analysis of Marksans Pharma
-
Table Product and Service Introduction of Marksans Pharma
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Assertio Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Assertio Therapeutics
-
Figure Sales and Growth Rate Analysis of Assertio Therapeutics
-
Figure Revenue and Market Share Analysis of Assertio Therapeutics
-
Table Product and Service Introduction of Assertio Therapeutics
-
Table Company Profile and Development Status of Intas
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas
-
Figure Sales and Growth Rate Analysis of Intas
-
Figure Revenue and Market Share Analysis of Intas
-
Table Product and Service Introduction of Intas
-
Table Company Profile and Development Status of TEVA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TEVA
-
Figure Sales and Growth Rate Analysis of TEVA
-
Figure Revenue and Market Share Analysis of TEVA
-
Table Product and Service Introduction of TEVA
-
Table Company Profile and Development Status of Sailike
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sailike
-
Figure Sales and Growth Rate Analysis of Sailike
-
Figure Revenue and Market Share Analysis of Sailike
-
Table Product and Service Introduction of Sailike
-
Table Company Profile and Development Status of Glenmark
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark
-
Figure Sales and Growth Rate Analysis of Glenmark
-
Figure Revenue and Market Share Analysis of Glenmark
-
Table Product and Service Introduction of Glenmark
-
